Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,133Revenue (TTM) $M2,018Net Margin (%)5.3Altman Z-Score3.9
Enterprise Value $M3,824EPS (TTM) $3.7Operating Margin %7.8Piotroski F-Score7
P/E(ttm)38.5Beneish M-Score-2.3Pre-tax Margin (%)6.9Higher ROA y-yY
Price/Book1.610-y EBITDA Growth Rate %4.5Quick Ratio3.1Cash flow > EarningsY
Price/Sales2.15-y EBITDA Growth Rate %-7.7Current Ratio4.4Lower Leverage y-yY
Price/Free Cash Flow106y-y EBITDA Growth Rate %-6.4ROA % (ttm)3.0Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)4.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M29.4ROIC % (ttm)5.8Gross Margin Increase y-yY

Gurus Latest Trades with BIO.B

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

BIO.B is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

BIO.B: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Magni GiovanniEVP, Chief Strategy Officer 2014-12-12Sell5,000$117.3819.76view
SODERBERG SHAWN MARIEEVP, General Counsel, Sec 2014-12-03Sell83$12017.15view
HERTIA JOHNExecutive Vice President 2014-11-25Sell6,000$119.3917.75view
TSINGOS CHRISTINE AEVP and CFO 2014-11-20Sell1,326$115.8521.35view
GOETZ JOHNEVP, COO 2014-11-19Sell4,891$114.4122.87view
HUTTON RONALD WVice President and Treasurer 2014-11-13Sell3,066$111.6225.95view
SCHWARTZ STEVEN D10% Owner 2014-11-13Sell530$111.9325.6view
TSINGOS CHRISTINE AEVP and CFO 2014-11-12Sell7,000$112.2225.27view
STARK JAMES RVP, Corporate Controller 2014-11-11Sell4,257$112.624.85view

Press Releases about BIO.B :

Quarterly/Annual Reports about BIO.B:

    News about BIO.B:

    Articles On GuruFocus.com
    David Herro: Brexit Reaction Jun 24 2016 
    How Will the Brexit Affect Small-Caps? - Royce Funds Commentary Jun 24 2016 
    Steve Mandel Exits Position in Williams Companies in 1st Quarter Jun 24 2016 
    This Sparkling Water Maker Rallies Forward Jun 24 2016 
    Joel Greenblatt Invests in Swift Transportation Jun 24 2016 
    British Pound Exchange Rates Plummet Post Brexit Jun 24 2016 
    Why I Built a Liquid Alternative Robo Advisor Jun 24 2016 
    DineEquity Positioned for Growth Jun 24 2016 
    Under Armour's P/S Ratio Near Its 10-Year Low Jun 23 2016 
    Conflicting Views Exist about the Tesla-SolarCity Acquisition Jun 23 2016 

    More From Other Websites
    Bio-Rad Unveils Amplichek II Quality Control, the First in a Series of Controls for the Molecular... May 23 2016
    Bio-Rad Laboratories, Inc. :BIO.B-US: Earnings Analysis: Q1, 2016 By the Numbers May 17 2016
    Bio-Rad posts 1Q profit May 05 2016
    Bio-Rad posts 1Q profit May 05 2016
    Bio-Rad posts 1Q profit May 05 2016
    Bio-Rad Reports First-Quarter 2016 Currency-Neutral Revenue Growth of Nearly 4 Percent May 05 2016
    Bio-Rad to Report First-Quarter 2016 Financial Results Thursday, May 5, 2016 Apr 13 2016
    Bio-Rad Laboratories, Inc. Earnings Analysis: 2015 By the Numbers Feb 29 2016
    Bio-Rad Announces CE IVD Marking of Its QX200 Droplet Digital PCR System for Use as an In Vitro... Feb 25 2016
    Bio-Rad Reports Fourth-Quarter and Full-Year 2015 Financial Results Feb 25 2016
    CORRECTION - Bio-Rad to Report Fourth-Quarter and Full-Year 2015 Financial Results Thursday,... Feb 16 2016
    Bio-Rad Expands Its Cell Biology Portfolio With High Performance Flow Cytometer Feb 08 2016
    Bio-Rad to Report Fourth-Quarter and Full-Year 2015 Financial Results Thursday, February 25, 2016 Feb 02 2016
    Bio-Rad Joins Food Safety Consortium With IBM and Mars, Incorporated Jan 12 2016
    Bio-Rad and Illumina to Co-Develop Comprehensive Solution for Single-Cell Genomics Jan 11 2016
    Bio-Rad Named One of the 2015 Top 100 Bay Area Innovators by Thomson Reuters Jan 05 2016
    Bio-Rad Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : December 25,... Dec 25 2015
    Bio-Rad's TANGO infinity Receives FDA 510(k) Clearance for U.S. Markets Dec 21 2015
    FDA Okays Bio-Rad D-100 for HbA1c (Diabetes) Testing Dec 21 2015
    Bio-Rad Laboratories, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 17 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)